Search

Search Results
Results 1051 - 1060 of 1533 for multiple myeloma
  • Pomalyst
    Drug - 23 Feb 2024
    Consumer Medicine Information (CMI) about Pomalyst intended for persons living in Australia.
  • What Does the Future of Liquid Biopsies Look Like?
    Health - 12 Sep 2023
    Liquid biopsy, or the evaluation of malignancies using biomarkers found in bodily fluids, has gained popularity in recent years. Technologies that can detect and describe cancers in minimally invasive...
  • Chimeric antigen receptors (CARs) and their use in novel cancer therapies
    White Paper - 25 Apr 2023
    In this article, Sino Biological demonstrates how Chimeric Antigen Receptors (CARs) can be utilized in novel cancer therapies, a change from the usual application of CARs, which heavily feature...
  • Single B cell screening: How it aids in antibody discovery
    White Paper - 16 Mar 2023
    Streamlined antibody discovery processes are of paramount importance to therapeutic development, single B cell screening is a major part of this and thus an optimized, high-throughput process is...
  • Lenalidomide-Teva
    Drug - 24 Jan 2023
    Consumer Medicine Information (CMI) about Lenalidomide-Teva intended for persons living in Australia.
  • Study elucidates the potential role of STRO-001 in B-cell non-Hodgkin lymphoma
    News - 18 Jan 2023
    A new research paper was published in Oncotarget's Volume 14 on January 12, 2023, entitled, "Targeting CD74 in B-cell non-Hodgkin lymphoma with the antibody-drug conjugate STRO-001."
  • Congenital vs Acquired Facial Palsy
    Health - 3 Jan 2023
    Facial palsy or paralysis arises as a result of injury to the seventh cranial nerve, which is called the facial nerve. This nerve has its origins in the pons and winds its way through the skull,...
  • Interleukin 6 and Disease
    Health - 15 Dec 2022
    Interleukin-6 (IL-6) is a multifunctional cytokine with a wide range of immune activities and a strong ability to trigger the acute phase response in host defence.
  • Novel molecular imaging radiotracer can precisely diagnose multiple cancers
    News - 20 Nov 2022
    A new molecular imaging radiotracer can precisely diagnose a variety of cancers, providing a roadmap to identify patients who may benefit from targeted radionuclide therapies.
  • Bortezomib-Teva
    Drug - 11 Jan 2022
    Consumer Medicine Information (CMI) about Bortezomib-Teva intended for persons living in Australia.

Terms

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

Provide Feedback